[PHARMA] YoY Annualized Quarter Result on 30-Sep-2016 [#3]

Announcement Date
21-Nov-2016
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2016
Quarter
30-Sep-2016 [#3]
Profit Trend
QoQ- -7.24%
YoY- -31.7%
Quarter Report
View:
Show?
Annualized Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 2,806,462 2,384,416 2,281,018 2,141,608 2,012,216 1,994,440 1,838,372 7.30%
PBT 62,145 77,706 70,930 90,597 118,673 116,968 79,986 -4.11%
Tax -23,097 -26,160 -27,065 -28,252 -27,282 -40,162 -32,661 -5.60%
NP 39,048 51,546 43,865 62,345 91,390 76,805 47,325 -3.15%
-
NP to SH 39,172 50,708 42,697 61,913 90,642 76,196 45,849 -2.58%
-
Tax Rate 37.17% 33.67% 38.16% 31.18% 22.99% 34.34% 40.83% -
Total Cost 2,767,414 2,332,869 2,237,153 2,079,262 1,920,825 1,917,634 1,791,046 7.51%
-
Net Worth 516,387 522,618 531,892 530,907 534,070 507,513 473,857 1.44%
Dividend
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Div 29,557 48,535 44,973 44,889 79,389 55,239 33,903 -2.25%
Div Payout % 75.46% 95.71% 105.33% 72.50% 87.59% 72.50% 73.95% -
Equity
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Net Worth 516,387 522,618 531,892 530,907 534,070 507,513 473,857 1.44%
NOSH 261,229 260,505 259,821 258,979 258,880 258,935 258,938 0.14%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin 1.39% 2.16% 1.92% 2.91% 4.54% 3.85% 2.57% -
ROE 7.59% 9.70% 8.03% 11.66% 16.97% 15.01% 9.68% -
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 1,076.09 917.05 879.14 826.94 777.28 770.25 709.97 7.17%
EPS 15.01 19.51 16.45 23.91 35.01 29.43 17.71 -2.71%
DPS 11.33 18.67 17.33 17.33 30.67 21.33 13.09 -2.37%
NAPS 1.98 2.01 2.05 2.05 2.063 1.96 1.83 1.32%
Adjusted Per Share Value based on latest NOSH - 259,146
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
RPS 194.72 165.44 158.27 148.59 139.62 138.38 127.55 7.30%
EPS 2.72 3.52 2.96 4.30 6.29 5.29 3.18 -2.56%
DPS 2.05 3.37 3.12 3.11 5.51 3.83 2.35 -2.24%
NAPS 0.3583 0.3626 0.369 0.3684 0.3706 0.3521 0.3288 1.44%
Price Multiplier on Financial Quarter End Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 30/09/19 28/09/18 29/09/17 30/09/16 30/09/15 30/09/14 30/09/13 -
Price 2.44 2.89 4.14 5.58 6.50 4.63 4.82 -
P/RPS 0.23 0.32 0.47 0.67 0.84 0.60 0.68 -16.52%
P/EPS 16.25 14.82 25.16 23.34 18.56 15.73 27.22 -8.23%
EY 6.16 6.75 3.97 4.28 5.39 6.36 3.67 9.01%
DY 4.64 6.46 4.19 3.11 4.72 4.61 2.72 9.30%
P/NAPS 1.23 1.44 2.02 2.72 3.15 2.36 2.63 -11.89%
Price Multiplier on Announcement Date
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Date 20/11/19 19/11/18 15/11/17 21/11/16 26/11/15 21/11/14 19/11/13 -
Price 2.21 3.09 3.82 5.70 6.50 4.45 4.72 -
P/RPS 0.21 0.34 0.43 0.69 0.84 0.58 0.66 -17.36%
P/EPS 14.71 15.84 23.21 23.84 18.56 15.12 26.66 -9.43%
EY 6.80 6.31 4.31 4.19 5.39 6.61 3.75 10.42%
DY 5.13 6.04 4.54 3.04 4.72 4.79 2.77 10.81%
P/NAPS 1.12 1.54 1.86 2.78 3.15 2.27 2.58 -12.97%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ & YoY figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment